Vimentin Protein In Situ Expression Predicts Less Tumor Metastasis and Overall Better Survival of Endometrial Carcinoma
Table 2
Clinicopathological characteristics of the 309 presented type 1 EC cases.
Characteristics
Vimentin negative
Vimentin positive
value
Age (years)
57 (30-72)
59 (37-79)
57 (30-93)
0.178
Gestation
2 (0-8)
2 (0-5)
2 (0-8)
0.322
Parity
1 (0-4)
1 (0-3)
1 (0-4)
0.911
FIGO stage
<0.001
I
235
26 (55.32%)
209 (79.77%)
II
25
3 (6.38%)
22 (8.40%)
III
39
13 (27.66%)
26 (9.92%)
IV
10
5 (10.64%)
5 (1.91%)
Postmenopause
0.605
Yes
188
27 (57.45%)
161 (61.45%)
No
121
20 (42.55%)
101 (38.55%)
Diabetes
0.253
Yes
72
14 (29.79%)
58 (22.13%)
No
237
33 (70.21%)
204 (77.86%)
Hypertension
0.402
Yes
147
25 (53.19%)
122 (46.56%)
No
162
22 (46.81%)
140 (53.44%)
Hypercholesteremia
0.624
Yes
69
12 (25.53%)
57 (22.27%)
No
234
35 (74.47%)
199 (77.73%)
NA
6
BMI (kg/m2)
0.079
<18.5
6
3 (6.52%)
3 (1.15%)
18.5-23.9
77
10 (21.74%)
67 (25.67%)
24.0-27.9
100
17 (36.96%)
83 (31.89%)
≥28.0
124
16 (34.78%)
108 (41.49%)
NA
2
Hypertriglyceridemia
0.723
Yes
30
4 (8.51%)
26 (10.20%)
No
272
43 (91.49%)
229(89.80%)
NA
7
Histologic grade
0.041
1
106
12 (25.53%)
94 (36.15%)
2
162
24 (51.06%)
138 (53.08%)
3
39
11 (23.41%)
28 (10.77%)
NA
2
Positive lymph nodes
0.008
Yes
26
9 (19.15%)
17(6.49%)
No
283
38 (80.85%)
245 (91.51%)
LVSI
0.007
Yes
54
15 (31.91%)
39(14.89%)
No
255
32 (68.09%)
223 (85.11%)
MI
0.241
<50%
221
29 (61.70%)
192(73.28%)
>50%
88
18 (38.30%)
70 (26.72%)
Vital state
0.009
Alive
281
40 (85.11%)
241 (96.40%)
Dead
16
7 (14.89%)
9 (3.60%)
NA
12
EC: endometrial carcinoma; FIGO: Federation International of Gynecology and Obstetrics Association; BMI: body mass index; NA: NA means that the data is not available; LVSI: lymph vascular space invasion; MI: myometrium invasion. The ages in the table are in years and are shown as medians and ranges.
